Adlyfe, Inc.

Protein detection technology developer secures $3.3M in series A round

Published in Lab Business Week, February 12th, 2006

Adlyfe, Inc., a diagnostic company located in Rockville, Maryland, closed a Series A financing to further develop its conformation-based protein detection and amplification technology.

Adlyfe's technology is significant in its potential impact in the early diagnosis and treatment of protein conformational animal and human diseases including Mad Cow Disease, Alzheimer and related wasting diseases.

Investors in the round include Canaan Partners and Burrill Associates. Seth Rudnick, from Canaan, and Ann Hanham, from Burrill, will join the Adlyfe board. "The diagnosis of misfolded proteins is a significant step on the road to both protecting populations...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-02-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry